An interventional study of Observation in Inflammatory Bowel Disease (IBD), Inflammation and Nutrition, sponsored by Istinye University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-09-18.
Sponsored by Istinye University · Not applicable, Interventional, and Prevention
Aims: This study aimed to assess nutritional status, dietary habits, meal patterns, gastrointestinal symptoms, quality of life, and depression in Inflammatory Bowel Disease (IBD) patients.
Methods: Data were collected at a university hospital using the 24-Hour Dietary Recall, IBD Quality of Life Questionnaire, Beck Depression Inventory II, and the Gastrointestinal Symptom Rating Scale.
Inflammatory Bowel Disease (IBD), which is divided into Ulcerative Colitis and Crohn's Disease, is influenced by various environmental factors, including nutrition, and significantly reduces the quality of life. This study included 50 individuals aged 18-75 who were diagnosed with Inflammatory Bowel Disease by a physician, had no communication difficulties, and were able to make their own food choices. The study aimed to evaluate the nutritional status, dietary habits, food consumption frequencies, and meal patterns of the patients and, based on these data, to determine their gastrointestinal symptoms, quality of life, and depression status. The study commenced with ethical approval and was conducted with patients at the Gastroenterology Clinic of Istanbul University Cerrahpaşa Medical Faculty Hospital between August 2023 and September 2023. The research is cross-sectional. Data were collected using the General Information and Nutrition Behaviors Questionnaire, Food Frequency Questionnaire, 24-Hour Dietary Recall, Inflammatory Bowel Disease Quality of Life Questionnaire, Beck Depression Inventory, and Gastrointestinal Symptom Rating Scale.
1,460 studies on the registry are indexed under Inflammatory Bowel Diseases; 438 are open to participants now.
This study's enrollment of 50 is below the median of 70 across 770 interventional studies indexed under Inflammatory Bowel Diseases.
Browse Inflammatory Bowel Diseases studies →Istinye University is the lead sponsor of 207 studies on the registry; 88 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: Observation
IBD patients
Weight
kg
Time frame: Baseline
Height
cm
Time frame: Baseline
24-Hour Dietary Recall
Time frame: 24-Hour Dietary Recall
IBD Quality of Life Questionnaire
To assess quality of life, the "Inflammatory Bowel Disease Quality of Life Questionnaire," consisting of 36 items and evaluating systemic symptoms, bowel symptoms, functional impairment, social impairment, and emotional functioning, was used. A higher score is associated with better quality of life.
Time frame: Baseline
Beck Depression Inventory II
The Beck Depression Inventory-II (BDI-II), a 21-item self-report questionnaire assessing characteristic attitudes and symptoms of depression, was administered at baseline (single time point, at questionnaire administration). Each item is scored on a 4-point scale (0-3), with a total score range of 0-63. Higher scores indicate greater severity of depression, classified as minimal (0-13), mild (14-19), moderate (20-28), and severe (29-63).
Time frame: Baseline
Gastrointestinal Symptom Rating Scale
The Gastrointestinal Symptom Rating Scale (GSRS), a 15-item questionnaire comprising five subcategories (abdominal pain, indigestion, diarrhea, constipation, and reflux), was administered at baseline (single time point, at questionnaire administration). Each item is scored on a 7-point Likert scale (1-7), yielding a total score range of 15-105, with higher scores indicating more severe gastrointestinal symptoms.
Time frame: Baseline
Plan to share: No
This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istinye University